Evidence map›Paper›PMID 31924738›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection.

Rakesh Bam, Patrick S Lown, Lawrence A Stern, Karina Sharma, Katheryne E Wilson, Gregory R Bean, Amelie M Lutz, Ramasamy Paulmurugan, Benjamin J Hackel, Jeremy Dahl and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Molecular Ultrasound Imaging.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Rakesh BamDepartment of Radiology, Stanford University School of Medicine, Stanford, California.ORCID 0000-0003-4067-3798
Patrick S LownChemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota.
Lawrence A SternChemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-3369-7495
Karina SharmaDepartment of Radiology, Stanford University School of Medicine, Stanford, California.
Katheryne E WilsonDepartment of Radiology, Stanford University School of Medicine, Stanford, California.ORCID 0000-0003-1388-9446
Gregory R BeanDepartment of Pathology, Stanford University School of Medicine, Stanford, California.ORCID 0000-0003-2866-8283
Amelie M LutzDepartment of Radiology, Stanford University School of Medicine, Stanford, California.
Ramasamy PaulmuruganDepartment of Radiology, Stanford University School of Medicine, Stanford, California.ORCID 0000-0001-7155-4738
Benjamin J HackelChemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota.
Jeremy DahlDepartment of Radiology, Stanford University School of Medicine, Stanford, California. jjdahl@stanford.edu.ORCID 0000-0001-9877-452X
Lotfi Abou-ElkacemDepartment of Radiology, Stanford University School of Medicine, Stanford, California.
Stanford Medicine · USUniversity of Minnesota · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast CancerR41CA213544 · NCI · NUVOX PHARMA, LLC · PI DAHL, JEREMY, UNGER, EVAN CHARLES · 2016 to 2016
$299k
Spectroscopic Photoacoustic Molecular Imaging for Breast Lesion CharacterizationK99EB023279 · NIBIB · STANFORD UNIVERSITY · PI WILSON, KATHERYNE E · 2017 to 2018
$152k
NCI NIH HHS R41 CA213544NIBIB NIH HHS K99 EB023279
6 · The paper itself

Abstract

purposeHuman B7-H3 (hB7-H3) is a promising molecular imaging target differentially expressed on the neovasculature of breast cancer and has been validated for preclinical ultrasound (US) imaging with anti-B7-H3-antibody-functionalized microbubbles (MB). However, smaller ligands such as affibodies (ABY) are more suitable for the design of clinical-grade targeted MB. EXPERIMENTAL

designBinding of ABY

resultsABY

conclusionsMB

Indexed as

AnimalsAntibodies, MonoclonalB7 AntigensBreast NeoplasmsContrast MediaDisease Models, AnimalFemaleMiceMice, NudeMice, TransgenicMicrobubblesMolecular ImagingNeovascularization, PathologicUltrasonographyAntibodies, MonoclonalB7 AntigensCD276 protein, humanContrast Media

Identifiers

PMID31924738
PMCPMC7196517
OpenAlexW3000630873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.